tiprankstipranks
Trending News
More News >
Bioxcel Therapeutics Inc (BTAI)
NASDAQ:BTAI
US Market

Bioxcel Therapeutics (BTAI) Cash flow

Compare
1,903 Followers

Bioxcel Therapeutics Cash Flow

BTAI's free cash flow for Q3 2025 was $-18.79M. For the 2025 fiscal year, BTAI's free cash flow was decreased by $83.00M and operating cash flow was $-18.79M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -72.03M$ -155.01M$ -135.34M$ -82.15M$ -66.35M
Investing Cash Flow
$ 0.00$ -20.00K$ -139.00K$ -445.00K$ -316.00K
Financing Cash Flow
$ 36.66M$ 26.52M$ 96.24M$ 102.45M$ 247.36M
End Cash Position
$ 29.85M$ 65.22M$ 193.72M$ 232.97M$ 213.12M
Free Cash Flow
$ -72.03M$ -155.03M$ -135.48M$ -82.60M$ -66.67M
Currency in USD

Bioxcel Therapeutics Cash Flow